Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

May 05, 2013

A mobile MSF TB surgery mission has successfully completed surgery on six DR-TB patients in Yeravan, Armenia.

March 15, 2012

As TB cases in Armenia rise at an alarming pace, MSF is stepping up "patient-centered" treatment of the deadly disease.

March 23, 2010

MSF is the only organization treating patients with drug-resistant tuberculosis in Armenia.

March 22, 2010

Along with medical staff, social workers and psychologists are an integral part of the MSF TB team in Armenia

Pages